康臣药业(01681)11月28日斥资290.4万港元回购19.6万股

Core Viewpoint - 康臣药业 announced a share buyback plan, intending to repurchase 196,000 shares at a total cost of HKD 2.904 million, scheduled for November 28, 2025 [1] Company Summary - 康臣药业 plans to spend HKD 2.904 million for the repurchase of 196,000 shares [1]